Glycation-Linked Erythrocyte Mechanical Dysfunction, Microvascular Transport–Unloading Mismatch, and Glycohypoxia in Type 2 Diabetes—A Quantitative Reanalysis and Biophysical Modeling Study

Background: Chronic hyperglycemia may impair oxygen handling through hemoglobin glycation, altered 2,3-BPG regulation, spectrin–ankyrin–Band 3 remodeling, oxidative injury, and PIEZO1–Ca²⁺–Gardos-dependent volume changes. Whether mechanical constraints on capillary erythrocyte transit can offset oxygen-unloading advantages remains unresolved. Methods: We quantitatively reanalyzed published human erythrocyte mechanical and microvascular data, reconstructing within-study effects without pooling incompatible assays or conflating diabetes subtypes. A conditional Hill-based capillary transport–unloading crossover (CTUC) model coupled calculated saturation differences with hypothetical effective erythrocyte flux across 36 pressure–cooperativity scenarios. Aggregate complete blood count data evaluated an exploratory mechanical index (eRMI₀ = RDW-CV × MCHC/MCV). Results: In a mixed-diabetes cohort (81 patients; 78 controls), half-maximal elongation stress increased 17.27% (Hedges’ g = 0.635; 95% CI, 0.316–0.953). Diabetic foot ulcer cases exhibited 4.09% lower elongation (g = 0.780; 95% CI, −0.090–1.650). Lower deformability was associated with prevalent retinopathy (adjusted OR = 2.81; 95% CI, 1.21–6.49) and 6.95-percentage-point lower deep-plexus vessel density. For P₅₀ values of 26.7 versus 28.3 mmHg, assumed inlet/outlet PO₂ of 100/40 mmHg, and Hill coefficient 2.7, modeled fractional unloading improved by 11.69%; nevertheless, a hypothetical 10.47% loss of effective erythrocyte flux entirely nullified this advantage within the normalized proxy. Crossover thresholds spanned 3.52%–13.60%. Conversely, lower P₅₀ (26.2 mmHg) with a hypothetical flux ratio of 0.90 reduced the proxy to 86.72% of reference. Aggregate eRMI₀ shifted inconsistently (−1.52% versus +4.88%). Discussion: These findings highlight a potential mismatch between per-cell oxygen-release capacity and effective microvascular cell transport. Glycation-associated allosteric, metabolic–redox, and membrane–cytoskeletal alterations provide plausible, unverified links. Heterogeneous assays, cross-sectional evidence, and missing paired flux–oxygenation measurements limit causal inference. Conclusion: CTUC defines a testable mathematical compensation boundary, not a measured clinical threshold, for investigating transport-related amplification of glycohypoxia; eRMI₀ remains unvalidated.